Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

Background. The development of radical therapy for multiple myeloma (MM) is still a pressing problem. This progressive disease requires repeated courses of therapy using drugs without cross-resistance. The prognosis of “double refractory” MM which is resistant to key antitumor drugs, first generatio...

Full description

Bibliographic Details
Main Authors: AV Petrov, DV Motorin, OS Pokrovskaya, ES Urnova, MV Nareiko, DV Babenetskaya, YuA Alekseeva, LL Girshova, LP Mendeleeva, AYu Zaritskii
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-07-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
multiple myeloma
“double-refractoriness”
immunomodulating agents
pomalidomide
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/09/10.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2017/09/10.pdf

Similar Items